Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tykerb and Xeloda in refractory advanced colorectal cancer
NCT00574171Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Sep 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in colorectal cancer (CRC), sponsored by University of Wisconsin–Madison. Started Sep 2007; status: completed.
02
Drugs
lapatinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00574171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00574171.